Trevi Therapeutics Provides Update on Haduvio's Clinical Development Program

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/28/2026

1. NVDA
2. MPLT
3. USO
4. BSP
5. XFLT
6. HCA
7. ITG
8. CNI
9. CAPR
10. SPY

Go back to Trevi Therapeutics Provides Update on Haduvio's Clinical Development Program
(NASDAQ: TRVI) Delayed: 18.12 +0.58 (3.31%)
Previous Close $17.54    52 Week High $ 
Open $17.74    52 Week Low $ 
Day High $18.46    P/E N/A 
Day Low $17.60    EPS $ 
Volume 1,741,453